A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes
- 10 April 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 145 (2), 381-388
- https://doi.org/10.1007/s10549-014-2944-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinomaJournal of Pineal Research, 2013
- Melatonin and its analogs in insomnia and depressionJournal of Pineal Research, 2012
- A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkersCancer Causes & Control, 2012
- Novel melatonin-based therapies: potential advances in the treatment of major depressionThe Lancet, 2011
- Prevalence, Severity, and Correlates of Sleep-Wake Disturbances in Long-Term Breast Cancer SurvivorsJournal of Pain and Symptom Management, 2010
- One-Year Outcomes of a Behavioral Therapy Intervention Trial on Sleep Quality and Cancer-Related FatigueJournal of Clinical Oncology, 2009
- Insomnia and its treatment in women with breast cancerSleep Medicine Reviews, 2006
- Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysisBMJ, 2006
- Melatonin–estrogen interactions in breast cancerJournal of Pineal Research, 2005
- The CES-D ScaleApplied Psychological Measurement, 1977